Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

SMER28 can reduce beta-amyloid accumulation in patients with Alzheimer's disease

Study: Moderate drinking can reduce risk of dementia even among older adults

Study: Moderate drinking can reduce risk of dementia even among older adults

Researchers find new strategy for long-term care of seniors

Researchers find new strategy for long-term care of seniors

North Shore-LIJ launches new prenatal quality initiative

North Shore-LIJ launches new prenatal quality initiative

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

hUCBs and MenSCs transplant may offer future therapeutic benefit for AD, stroke, ALS

Prevalence of bipolar disorder

Prevalence of bipolar disorder

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Longer looks: Best health policy picks from thought-provoking publications

Longer looks: Best health policy picks from thought-provoking publications

Boston Blades' new team to raise money, awareness for Alzheimer's research

Boston Blades' new team to raise money, awareness for Alzheimer's research

Researchers transform human embryonic stem cell into neuron that dies early in Alzheimer's disease

Researchers transform human embryonic stem cell into neuron that dies early in Alzheimer's disease

New study finds liver instead of the brain as source of Alzheimer’s plaques

New study finds liver instead of the brain as source of Alzheimer’s plaques

Lactate plays critical role in formation of long-term memory

Lactate plays critical role in formation of long-term memory

Efficiency of brain function depends on family's genetic makeup

Efficiency of brain function depends on family's genetic makeup

Neuropathologist receives AAN Potamkin Prize for Alzheimer's disease research

Neuropathologist receives AAN Potamkin Prize for Alzheimer's disease research

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders

Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

ITI, Takeda collaborate to develop and commercialize PDE1 inhibitors for schizophrenia

Ibuprofen may protect against development of Parkinson's disease

Ibuprofen may protect against development of Parkinson's disease

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.